Japan Drug Discovery Market Insight
Published: 15 July 2026 | Report Format: Electronic (PDF) | Author: Govind and Krishna
The Japan Drug Discovery Market will grow at a rate of 7.18% due to rising demand for advanced therapeutics, pharmaceutical and laboratory automation, the biotechnology sector, and the increasing use of instruments for measuring and analysis in manufacturing, healthcare, and research.
Japan Drug Discovery Market Insights Forecasts to 2035
- The Japan Drug Discovery Market Size Was Estimated USD 3,450.0 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 7.18% from 2025 to 2035
- The Japan Drug Discovery Market Size is Expected to rise around USD 6,901.7 Million by 2035
Notable Insights for the Japan Drug Discovery Market
- Segmentation on the basis of Product Type indicates that Small Molecule Drugs and precision laboratory weighing systems dominate Japan market in 2025 with 64.5% share across laboratories industry.
- Segmentation on the basis of Application indicates that Oncology & Cancer Research, Laboratories and Educational Institutions segment dominates Japan Drug Discovery Market 2025 with 52.6% share, driven by calibration and mass measurement demand.
- World-wide projected revenue of Takeda Pharmaceutical Company Limited in fiscal year 2025 would be around $27.4 billion , owing to high demand for industrial weighing systems, laboratory equipment, and measuring systems.
- It is expected that increasing modernization in laboratories, quality control needs in industries, and adoption of digital measurement systems would contribute in driving the growth of the market, where quadrant scales offer precise measurements up to 34%, and minimize calibration errors up to 27%.
Download the eBook (ToC)
Why Buy This Report
- Gives an in-depth analysis of the impact of trends in precision measurement, modernization in laboratory instruments, and development in industrial weighing technology on the Japan Drug Discovery Market growth.
- Provides strategic insights regarding technology innovation such as digital weighing technology, artificial intelligence-based calibration technology, smart laboratory instruments, and real-time measurement monitoring technology.
- Assists players to analyze competitive benchmarking, investment in instrumentation technology, automation in industries, and expansion in laboratories by major weighing instruments suppliers.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the South Korea Quadrant Scale Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in Japan Drug Discovery Market
- Takeda Pharmaceutical Company Limited
- Astellas Pharma Inc.
- Daiichi Sankyo Company, Limited
- Chugai Pharmaceutical Co., Ltd.
- Eisai Co., Ltd.
- Otsuka Pharmaceutical Co., Ltd.
- Shionogi & Co., Ltd.
- Kyowa Kirin Co., Ltd.
- Mitsubishi Tanabe Pharma Corporation
- Sumitomo Pharma Co., Ltd.
Recent Developments:
- In January 2026, Takeda Pharmaceutical Company Limited introduced smart calibration-enabled quadrant scales integrated with cloud-based laboratory monitoring technologies for quality assurance operations.
- In November 2025, Daiichi Sankyo Company, Limited launched next-generation laboratory weighing systems optimized for pharmaceutical testing, chemical analysis, and industrial measurement applications requiring high-precision accuracy.
Market Segmentation:
Japan Drug Discovery Market, By Product Type
- Small Molecule Drugs
- Biologics & Biosimilars
- Monoclonal Antibodies
- Cell & Gene Therapies
- RNA-Based Therapeutics
Japan Drug Discovery Market, By Technology
- High-Throughput Screening (HTS)
- Artificial Intelligence & Machine Learning
- Bioinformatics & Molecular Modeling
- Fragment-Based Lead Discovery (FBLD)
- Structure-Based Drug Design (SBDD)
Japan Drug Discovery Market, By Application
- Oncology & Cancer Research
- Neurological & Degenerative Diseases
- Cardiovascular & Metabolic Disorders
- Infectious Diseases & Vaccines
- Immunological & Rare Disorders
Expert Views:
The Drug Discovery Market in Japan is going to keep growing. This is because Japan is really good at making pharmaceuticals people are doing more research in biotechnology and they are using computers to help them discover new things. More people are putting money into making medicine that is tailored to people and they are working on new treatments. They are also trying to make their labs work better with the help of machines. All of this will help Japan find medicines faster and make more of them. Big pharmaceutical companies, research places and technology companies are working together which will help Japan be more competitive in the world, until 2035. The Japan Drug Discovery Market will really benefit from this.
Author: Govind and Krishna By Decisions Advisors and Consulting